ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 651,962 | $603,065 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 73,922 | $69 | 0.00% |
| MARSHALL WACE, LLP | 272,681 | $253,592 | 0.00% |
| Janney Montgomery Scott LLC | 30,000 | $28 | 0.00% |
| CITIGROUP INC | 582,196 | $538,531 | 0.00% |
| HSBC HOLDINGS PLC | 26,171 | $24,156 | 0.00% |
| Tower Research Capital LLC (TRC) | 16,074 | $14,868 | 0.00% |
| GOLDMAN SACHS GROUP INC | 48,077 | $44,471 | 0.00% |
| MORGAN STANLEY | 2,077,172 | $1,921,385 | 0.00% |
| Invesco Ltd. | 34,992 | $32,368 | 0.00% |
External links
This page lists ADAPTIMMUNE THERAPEUTICS PLC's shareholders in Q2 2023. To view ADAPTIMMUNE THERAPEUTICS PLC's shareholder history, click here.